JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

A Study on the Etiology, Severity, and Mortality of 3260 Patients With Acute Pancreatitis According to the Revised Atlanta Classification in Jiangxi, China Over an 8-Year Period.

Pancreas 2017 April
OBJECTIVES: Currently, the epidemiology of acute pancreatitis (AP) according to the Atlanta classification 2012 is rare. Thus, we aim to evaluate the etiology, severity, and mortality of AP according to Atlanta classification 2012 in Jiangxi, China.

METHODS: We analyzed 3260 hospitalized patients between 2005 and 2012 from AP database. The severity was classified by the Atlanta classification 2012.

RESULTS: 3260 patients were admitted. Cholelithiasis (58.7%), hyperlipidemia (14.3%), and alcohol (4.5%) were the top 3 etiologies. Besides, in 16.7% of patients, the etiology still unexplained. 1238 patients (38.0%) were categorized as mild, 1551 (47.6%) as moderate, and 471 (14.4%) as severe acute pancreatitis. Hyperlipidemia and alcohol were the more common cause in men, especially the younger and middle aged, whereas cholelithiasis were the more common cause in women, especially the elderly. The overall mortality of AP was 1.2% and 8.5% in severe acute pancreatitis. Meanwhile, both severe idiopathic and hyperlipidemic pancreatitis had significantly higher mortality rate than severe biliary pancreatitis.

CONCLUSIONS: Cholelithiasis was the main etiology in Jiangxi, China, and hyperlipidemia ranked second. There were different etiological proportion according to age, sex, and severity. Furthermore, the higher mortality rate occurred in severe idiopathic and hyperlipidemic pancreatitis, although there was no clear association between mortality and age.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app